BRIEF published on 05/19/2025 at 19:21, 8 months 16 days ago EB Development dépasse les 90 % du capital d'Eurobio Scientific Diagnostic In Vitro Réunion Financière Eurobio Scientific Développement EB 90 % Des Actions
BRIEF published on 05/19/2025 at 19:21, 8 months 16 days ago EB Development Surpasses 90% Stake in Eurobio Scientific In Vitro Diagnostics Eurobio Scientific EB Development Financial Meeting 90% Shareholding
PRESS RELEASE published on 05/19/2025 at 19:16, 8 months 16 days ago Eurobio Scientific : EB Development franchit à la hausse le seuil de 90% EB Development franchit à la hausse le seuil de 90% du capital d'Eurobio Scientific suite à une acquisition d'actions sur le marché. Prochain rendez-vous financier : Assemblée générale le 19 juin 2025 Franchissement De Seuil Assemblée Générale Diagnostic Médical Eurobio Scientific EB Development
PRESS RELEASE published on 05/19/2025 at 19:16, 8 months 16 days ago Eurobio Scientific: EB Development rises above 90% threshold Eurobio Scientific's shareholder EB Development surpasses 90% share capital threshold through market acquisitions. Financial meeting: Annual General Meeting on June 19, 2025 Share Capital Eurobio Scientific EB Development Financial Meeting 90% Threshold
BRIEF published on 04/29/2025 at 21:05, 9 months 5 days ago Availability of the 2024 annual financial report by Eurobio Scientific Investors In Vitro Diagnostics General Meeting Annual Report 2024 Eurobio Scientific
BRIEF published on 04/29/2025 at 21:05, 9 months 5 days ago Mise à disposition du rapport financier annuel 2024 par Eurobio Scientific Diagnostic In Vitro Assemblée Générale Investisseurs Rapport Annuel 2024 Eurobio Scientific
PRESS RELEASE published on 04/29/2025 at 21:00, 9 months 5 days ago Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Eurobio Scientific annonce la mise à disposition de son rapport financier annuel 2024 auprès du public et de l'AMF Assemblée Générale Investisseurs Rapport Financier Annuel Diagnostic Médical Eurobio Scientific
BRIEF published on 03/04/2025 at 20:08, 11 months ago Eurobio Scientific met fin à son contrat de liquidité Contrat De Liquidité TP ICAP Euronext Growth Diagnostic Médical Eurobio Scientific
BRIEF published on 03/04/2025 at 20:08, 11 months ago Eurobio Scientific terminates its liquidity contract Liquidity Contract TP ICAP Euronext Growth Medical Diagnosis Eurobio Scientific
PRESS RELEASE published on 03/04/2025 at 20:03, 11 months ago Eurobio Scientific : résiliation du contrat de liquidité Eurobio Scientific met fin au contrat de liquidité avec TP ICAP et communique sur ses moyens en compte. L'action est cotée sur Euronext Growth Paris Euronext Growth Paris Contrat De Liquidité Diagnostic Médical Fin Eurobio Scientific
Published on 02/05/2026 at 13:30, 37 minutes ago Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
Published on 02/05/2026 at 13:30, 37 minutes ago ESGold Expands Montauban Land Position Following 3D Geological Model Identifying Potential District-Scale Mineralized Corridor
Published on 02/05/2026 at 13:20, 47 minutes ago Guanajuato Silver Sees Significant Growth in Resources at Valenciana
Published on 02/05/2026 at 13:15, 52 minutes ago Avino Appoints Linda Broughton to The Board of Directors
Published on 02/05/2026 at 13:00, 1 hour 7 minutes ago urban-gro to Implement 1-for-25 Reverse Stock Split
Published on 02/05/2026 at 13:30, 36 minutes ago Ascory Bank ends its year of transformation in 2025 with positive results and starts 2026 with a new strategy and a new name
Published on 02/05/2026 at 13:04, 1 hour 2 minutes ago EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Published on 02/05/2026 at 12:48, 1 hour 18 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Published on 02/05/2026 at 12:45, 1 hour 21 minutes ago R.E.A. Holdings plc: Notification of Major Holdings
Published on 02/05/2026 at 11:47, 2 hours 19 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:30, 2 hours 37 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 2 hours 37 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 20 hours 2 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 20 hours 2 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 20 hours 22 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
